Home/TumorGen/Jeffrey K. Allen, Ph.D.
JK

Jeffrey K. Allen, Ph.D.

Founder, President & CEO

TumorGen

Therapeutic Areas

TumorGen Pipeline

DrugIndicationPhase
Anti-Metastatic Cell Cluster TherapyPrevention of Cancer MetastasisPre-clinical